[1] Wang H, Liu X, Zhao Y, et al. Incidence and pattern of traumatic spinal fractures and associated spinal cord injury resulting from motor vehicle collisions in China over 11 years: an observational study [J]. Medicine (Baltimore), 2016, 95(43): p. e5220.
[2] Yang R, Guo L, Huang L, et al. Epidemiological characteristics of traumatic spinal cord injury in Guangdong, China [J]. Spine (Phila Pa 1976), 2016. [Epub ahead of print].
[3] Jain NB, Ayers GD, Peterson EN, et al. Traumatic spinal cord injury in the United States, 1993-2012 [J]. JAMA, 2015, 313(22): 2236-2243.
[4] Zhang Y, Zhang L, Shen J, et al. Two-photon-excited fluorescence microscopy as a tool to investigate the efficacy of methylprednisolone in a mouse spinal cord injury model [J]. Spine (Phila Pa 1976), 2014, 39(8): E493-E499.
[5] Bhalala OG, Srikanth M, Kessler JA. The emerging roles of microRNAs in CNS injuries [J]. Nat Rev Neurol, 2013, 9(6): 328-339.
[6] Spinal cord injury facts and figures at a glance [J]. J Spinal Cord Med, 2012, 35(6): 480-481.
[7] Lee BB, Cripps RA, Fitzharris M, et al. The global map for traumatic spinal cord injury epidemiology: update 2011, global incidence rate [J]. Spinal Cord, 2014, 52(2): 110-116.
[8] Hua R, Shi J, Wang X, et al. Analysis of the causes and types of traumatic spinal cord injury based on 561 cases in China from 2001 to 2010 [J]. Spinal Cord, 2013, 51(3): 218-221.
[9] Mitchell RJ, Bambach MR. Personal injury recovery cost of pedestrian-vehicle collisions in New South Wales, Australia [J]. Traffic Inj Prev, 2016, 17(5): 508-514.
[10] Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: a review [J]. World J Stem Cells, 2014, 6(2): 120-133.
[11] Zhu T, Tang Q, Gao H, et al. Current status of cell-mediated regenerative therapies for human spinal cord injury [J]. Neurosci Bull, 2014, 30(4): 671-682.
[12] Poniatowski ŁA, Wojdasiewicz P, Krawczyk M, et al. Analysis of the Role of CX3CL1 (Fractalkine) and its receptor CX3CR1 in traumatic brain and spinal cord injury: insight into recent advances in actions of neurochemokine agents [J]. Mol Neurobiol, 2017, 54(3): 2167-2188.
[13] Xu M, Wang HF, Zhang YY, et al. Protection of rats spinal cord ischemia-reperfusion injury by inhibition of MiR-497 on inflammation and apoptosis: possible role in pediatrics [J]. Biomed Pharmacother, 2016, 81: 337-344.
[14] Strickland ER, Hook MA, Balaraman S, et al. MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair [J]. Neuroscience, 2011, 186: 146-160.
[15] Li J, Huang J, Dai L, et al. miR-146a, an IL-1beta responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4 [J]. Arthritis Res Ther, 2012, 14(2): R75.
[16] He QQ, Xiong LL, Liu F, et al. MicroRNA-127 targeting of mitoNEET inhibits neurite outgrowth, induces cell apoptosis and contributes to physiological dysfunction after spinal cord transaction [J]. Sci Rep, 2016, 6: 35205.
[17] He F, Ren Y, Shi E, et al. Overexpression of microRNA-21 protects spinal cords against transient ischemia [J]. J Thorac Cardiovasc Surg, 2016, 152(6): 1602-1608.
[18] Gaudet AD, Mandrekar-Colucci S, Hall JC, et al. miR-155 deletion in mice overcomes neuron-intrinsic and neuron-extrinsic barriers to spinal cord repair [J]. J Neurosci, 2016, 36(32): 8516-8532.
[19] Yunta M, Nieto-Díaz M, Esteban FJ, et al. MicroRNA dysregulation in the spinal cord following traumatic injury [J]. PLoS One, 2012, 7(4): e34534.
[20] Boon H, Sjögren RJ, Massart J, et al. MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression [J]. Physiol Rep, 2015, 3(11): e12622.
[21] Jee MK, Jung JS, Choi JI, et al. MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury [J]. Brain, 2012, 135(Pt 4): 1237-1252.
[22] Aldahmash A, Zaher W, Al-Nbaheen M, et al. Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration [J]. Ann Saudi Med, 2012, 32(1): 68-77.
[23] Liu NK, Wang XF, Lu QB, et al. Altered microRNA expression following traumatic spinal cord injury [J]. Exp Neurol, 2009, 219(2): 424-429.
[24] Chen X, Xia J, Xia Z, et al. Potential functions of microRNAs in starch metabolism and development revealed by miRNA transcriptome profiling of cassava cultivars and their wild progenitor [J]. BMC Plant Biol, 2015. 15: 33.
[25] Xie M, Zhang S, Yu B. MicroRNA biogenesis, degradation and activity in plants [J]. Cell Mol Life Sci, 2015, 72(1): 87-99.
[26] Das A, Ganesh K, Khanna S, et al. Engulfment of apoptotic cells by macrophages: a role of microRNA-21 in the resolution of wound inflammation [J]. J Immunol, 2014, 192(3): 1120-1129.
[27] Gao Y, Schug J, McKenna LB, et al. Tissue-specific regulation of mouse microRNA genes in endoderm-derived tissues [J]. Nucleic Acids Res, 2011, 39(2): 454-463.
[28] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 [J]. Cell, 1993, 75(5): 843-854.
[29] Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans [J]. Nature, 2000, 403(6772): 901-906.
[30] Tsai NP, Lin YL, Wei LN. MicroRNA mir-346 targets the 5'-untranslated region of receptor-interacting protein 140 (RIP140) mRNA and up-regulates its protein expression [J]. Biochem J, 2009, 424(3): 411-418.
[31] Kiriakidou M, Tan GS, Lamprinaki S, et al. An mRNA m7G cap binding-like motif within human Ago2 represses translation [J]. Cell, 2007, 129(6): 1141-1151.
[32] Mathonnet G, Fabian MR, Svitkin YV, et al. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F [J]. Science, 2007, 317(5845): 1764-1767.
[33] Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR [J]. Proc Natl Acad Sci U S A, 2007, 104(23): 9667-9672.
[34] Belle M, Terracol C, Castel-Lacanal E, et al. Evaluation of seating intervention effect for patient at Toulouse University Hospital's Wheelchair Seating Clinic (WSC) [J]. Ann Phys Rehabil Med, 2016, 59S: e27.
[35] García-Perdomo HA, Echeverría-García F, Tobías A. Effectiveness of phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction in patients with spinal cord trauma: systematic review and Meta-analysis [J]. Urol Int, 2017, 98(2): 198-204.
[36] Schomberg DT, Miranpuri GS, Chopra A, et al. Translational relevance of swine models of spinal cord injury [J]. J Neurotrauma, 2017, 34(3): 541-551.
[37] Huang JH, Cao Y, Zeng L, et al. Tetramethylpyrazine enhances functional recovery after contusion spinal cord injury by modulation of MicroRNA-21, FasL, PDCD4 and PTEN expression [J]. Brain Res, 2016, 1648(Pt A): 35-45.
[38] Genda Y, Arai M, Ishikawa M, et al. microRNA changes in the dorsal horn of the spinal cord of rats with chronic constriction injury: A TaqMan ® low density array study [J]. Int J Mol Med, 2013, 31(1): 129-137.
[39] Ziu M, Fletcher L, Savage JG, et al. Spatial and temporal expression levels of specific microRNAs in a spinal cord injury mouse model and their relationship to the duration of compression [J]. Spine J, 2014, 14(2): 353-360.
[40] Nakanishi K, Nakasa T, Tanaka N, et al. Responses of microRNAs 124a and 223 following spinal cord injury in mice [J]. Spinal Cord, 2010, 48(3): 192-196.
[41] Valencia-Sanchez MA, Liu J, Hannon GJ, et al. Control of translation and mRNA degradation by miRNAs and siRNAs [J]. Genes Dev, 2006,20(5): 515-524.
[42] 赵宇. 小鼠脊髓损伤后microRNA的表达变化及miR-124低表达和高表达转基因小鼠的建立[D]. 西安:第四军医大学, 2011.
[43] Louw AM, Kolar MK, Novikova LN, et al. Chitosan polyplex mediated delivery of miRNA-124 reduces activation of microglial cells in vitro and in rat models of spinal cord injury [J]. Nanomedicine, 2016, 12(3): 643-653.
[44] Zhao Y, Zhang H, Zhang D, et al. Loss of microRNA-124 expression in neurons in the peri-lesion area in mice with spinal cord injury [J]. Neural Regen Res, 2015, 10(7): 1147-1152.
[45] Chen X, He D, Dong XD, et al. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma [J]. Invest Ophthalmol Vis Sci, 2013, 54(3): 2248-2256.
[46] Zou D, Chen Y, Han Y, et al. Overexpression of microRNA-124 promotes the neuronal differentiation of bone marrow-derived mesenchymal stem cells [J]. Neural Regen Res, 2014, 9(12): 1241-1248.
[47] 武昊. 脊髓损伤后miR-152表达升高并抑制神经元突起生长[D]. 西安:第四军医大学, 2012.
[48] 陈琨. 小鼠脊髓损伤后microRNA-152对神经元突起再生作用和机制的研究[D]. 西安:第四军医大学, 2014.
[49] Izumi B, Nakasa T, Tanaka N, et al. MicroRNA-223 expression in neutrophils in the early phase of secondary damage after spinal cord injury [J]. Neurosci Lett, 2011, 492(2): 114-118.
[50] 孙炜俊. 大鼠损伤脊髓中microRNA-223的表达及与RhoB的相关性研究[D]. 福州:福建医科大学, 2015.
[51] Camps C, Saini HK, Mole DR, et al. Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia [J]. Mol Cancer, 2014, 13: 28.
[52] Huang X, Le QT, Giaccia AJ. MiR-210–micromanager of the hypoxia pathway [J]. Trends Mol Med, 2010, 16(5): 230-237.
[53] Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir [J]. Cell Cycle, 2010, 9(6): 1072-1083.
[54] Mei Y, Gao C, Wang K, et al. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia [J]. Cancer Sci, 2014, 105(4): 463-472.
[55] Wang J, Raimondo M, Guha S, et al. Circulating microRNAs in pancreatic juice as candidate biomarkers of pancreatic cancer [J]. J Cancer, 2014, 5(8): 696-705.
[56] Luft FC. Merely miR210 in mesenchymal stem cells–one size fits all [J]. J Mol Med (Berl), 2012, 90(9): 983-985.
[57] Xu J, Huang Z, Lin L, et al. MiR-210 over-expression enhances mesenchymal stem cell survival in an oxidative stress environment through antioxidation and c-Met pathway activation [J]. Sci China Life Sci, 2014, 57(10): 989-997.
[58] 邵建立,李志忠,张瑕,等. MiR-210inhibitor对大鼠背脊髓神经元细胞氧化应激的保护作用[J]. 中山大学学报(医学科学版), 2015, 36(3): 360-365.
[59] Ujigo S, Kamei N, Hadoush H, et al. Administration of microRNA-210 promotes spinal cord regeneration in mice [J]. Spine (Phila Pa 1976), 2014, 39(14): 1099-1107.
[60] Nieto-Diaz M, Esteban FJ, Reigada D, et al. MicroRNA dysregulation in spinal cord injury: causes, consequences and therapeutics [J]. Front Cell Neurosci, 2014, 8: 53.
[61] Lu P, Sun H, Zhang L, et al. Isocorydine targets the drug-resistant cellular side population through PDCD4-related apoptosis in hepatocellular carcinoma [J]. Mol Med, 2012, 18: 1136-1146.
[62] He J, Yue Y, Dong C, et al. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis [J]. Clin Invest Med, 2013, 36(2): E103-E111.
[63] Wang J, Li Y, Wang X, et al. Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-beta1/miR-21/PDCD4 pathway [J]. Basic Clin Pharmacol Toxicol, 2012, 111(2): 106-112.
[64] 佘飞,苏琴,张宪,等. 小鼠脊髓损伤组织高表达的microRNA-21对neuro-2a细胞PDCD4的影响[J]. 创伤外科杂志, 2015, 17(6): 546-549.
[65] Yang GD, Huang TJ, Peng LX, et al. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced apoptosis by suppressing PDCD4 and Fas-L [J]. PLoS One, 2013, 8(10): e78355.
[66] Cheng Y, Zhu P, Yang J, et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4 [J]. Cardiovasc Res, 2010, 87(3): 431-439.
[67] Wei J, Wang J, Zhou Y, et al. MicroRNA-146a contributes to SCI recovery via regulating TRAF6 and IRAK1 expression [J]. Biomed Res Int, 2016, 2016: 4013487.
[68] Li P, Teng ZQ, Liu CM. Extrinsic and intrinsic regulation of axon regeneration by MicroRNAs after spinal cord injury [J]. Neural Plast, 2016, 2016: 1279051.
[69] Xu Y, An BY, Xi XB, et al. MicroRNA-9 controls apoptosis of neurons by targeting monocyte chemotactic protein-induced protein 1 expression in rat acute spinal cord injury model [J]. Brain Res Bull, 2016, 121: 233-240.
[70] Wang T, Yuan W, Liu Y, et al. miR-142-3p is a potential therapeutic target for sensory function recovery of spinal cord injury [J]. Med Sci Monit, 2015, 21: 2553-2556.
